美国 · SEC FORM 4
Sana Biotechnology, Inc.
SANA · Nasdaq · CIK 0001770121 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
4 同一窗口内观察到的 Form 4 交易行
0 sales · 4 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2024-02-08 · NELSEN ROBERT.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 38,725,699
- 上期报告
- 41,374,811
- 日均成交量
- 4,323,617
- 回补天数
- 9.0
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2024-02-08 | NELSEN ROBERT | 买入 (P) | Common Stock | 1,090,909 | USD 5.50 | USD 6,000,000 | SEC 申报 ↗ |
| 2024-02-08 | BYBEE CLINTON; Burow Kristina; CRANDELL KEITH; GILLIS STEVEN | 买入 (P) | Common Stock | 1,090,909 | USD 5.50 | USD 6,000,000 | SEC 申报 ↗ |
| 2024-02-08 | ARCH Venture Fund IX Overage, L.P.; ARCH Venture Fund IX, L.P.; ARCH Venture Fund X Overage, L.P.; ARCH Venture Fund X, L.P.; ARCH Venture Partners IX Overage, L.P.; ARCH Venture Partners IX, L.P.; ARCH Venture Partners IX, LLC; ARCH Venture Partners X Overage, L.P.; ARCH Venture Partners X, L.P.; ARCH Venture Partners X, LLC | 买入 (P) | Common Stock | 1,090,909 | USD 5.50 | USD 6,000,000 | SEC 申报 ↗ |
| 2022-03-21 | Yang Patrick Y | 买入 (P) | Common Stock | 28,000 | USD 7.30 | USD 204,400 | SEC 申报 ↗ |
| 2021-02-03 | Bilenker Joshua H. | 买入 (P) | Common Stock | 20,000 | USD 25.00 | USD 500,000 | SEC 申报 ↗ |
Form 4 申报证据
22 transaction lines in the latest 365-day window; 128 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | Bishop Hans Edgar | 奖励／授予 (A) | Common Stock | 8,680 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-27 | PATEL DHAVALKUMAR DHIRAJLAL | 代扣税 (F) | Common Stock | 41,158 | USD 4.11 | USD 169,159 | SEC 申报 ↗ |
| 2026-08-26 | PATEL DHAVALKUMAR DHIRAJLAL | 期权行权／转换 (M) | Common Stock | 125,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (20 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | Bishop Hans Edgar | 奖励／授予 (A) | Common Stock | 8,680 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-27 | PATEL DHAVALKUMAR DHIRAJLAL | 代扣税 (F) | Common Stock | 41,158 | USD 4.11 | USD 169,159 | SEC 申报 ↗ |
| 2026-08-26 | PATEL DHAVALKUMAR DHIRAJLAL | 期权行权／转换 (M) | Common Stock | 125,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-06 | Bishop Hans Edgar | 奖励／授予 (A) | Common Stock | 6,297 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-06 | Bishop Hans Edgar | 奖励／授予 (A) | Common Stock | 7,763 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-09 | Wyrick Susan D. | 代扣税 (F) | Common Stock | 4,387 | USD 3.12 | USD 13,700 | SEC 申报 ↗ |
| 2026-03-09 | Harr Steve | 代扣税 (F) | Common Stock | 24,345 | USD 3.11 | USD 75,815 | SEC 申报 ↗ |
| 2026-03-07 | Wyrick Susan D. | 期权行权／转换 (M) | Common Stock | 3,250 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-07 | Harr Steve | 期权行权／转换 (M) | Common Stock | 50,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-06 | Wyrick Susan D. | 期权行权／转换 (M) | Common Stock | 10,416 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-06 | Harr Steve | 期权行权／转换 (M) | Common Stock | 41,666 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-03 | Wyrick Susan D. | 代扣税 (F) | Common Stock | 491 | USD 3.91 | USD 1,920 | SEC 申报 ↗ |
| 2026-03-02 | Wyrick Susan D. | 期权行权／转换 (M) | Common Stock | 1,525 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-05 | Wyrick Susan D. | 代扣税 (F) | Common Stock | 2,407 | USD 4.27 | USD 10,278 | SEC 申报 ↗ |
| 2026-01-05 | Bishop Hans Edgar | 奖励／授予 (A) | Common Stock | 6,157 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-02 | Wyrick Susan D. | 期权行权／转换 (M) | Common Stock | 7,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-12-15 | Wyrick Susan D. | 代扣税 (F) | Common Stock | 873 | USD 5.22 | USD 4,557 | SEC 申报 ↗ |
| 2025-12-13 | Wyrick Susan D. | 期权行权／转换 (M) | Common Stock | 3,400 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-12-04 | Wyrick Susan D. | 代扣税 (F) | Common Stock | 2,565 | USD 4.44 | USD 11,389 | SEC 申报 ↗ |
| 2025-12-03 | Wyrick Susan D. | 期权行权／转换 (M) | Common Stock | 10,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | SANA |
| CIK | 0001770121 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2836 Biological Products, (No Diagnostic Substances) |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 128 transaction lines from 2021-02-03 to 2026-10-05 8 P purchase lines · 31 S sale lines · 89 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.